Biotech IPO activity in the US has spiked for the second time this year, following an initial boost in Q1 2024. Largely ...

Take a closer look at 12 biotech unicorns, with a worth of more than $1 billion, that are trying to revolutionize the ...

Discover the major biotech partnerships, collaborations and mergers and acquisitions that made headlines in September 2024.

Learn how cancer tissue biobanks and insights into solid tumor heterogeneity are transforming drug discovery and leading to ...

Explore innovative treatments for spinal cord injury in clinical trials, including Lineage's OPC1 and NervGen's NVG-291, ...

The companies Candid Therapeutics, ArsenalBio, and eGenesis bagged the biggest private biotech investments in September 2024.

The recent uptick in the number of bird flu cases in the U.S. poses a threat to public health. The country’s health department has called on biotechs to develop vaccines to mitigate the outbreak. The ...